Brokerages Set Mettler-Toledo International, Inc. (NYSE:MTD) PT at $1,311.11

Key Points

• The consensus recommendation for Mettler-Toledo International, Inc. (NYSE:MTD) is a "Moderate Buy", with an average price target of $1,325.56.
• Recent insider transactions include significant stock sales by director Thomas P. Salice and CFO Shawn Vadala, indicating a decrease in their ownership of the company’s shares.
• Mettler-Toledo reported earnings of $10.09 EPS for the last quarter, surpassing estimates and projecting a FY 2025 guidance of 42.100-42.600 EPS.

Shares of Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten analysts that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $1,325.5556.

MTD has been the subject of several analyst reports. Bank of America increased their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a "neutral" rating in a research report on Monday. Evercore ISI decreased their price target on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Barclays initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target for the company. Citigroup increased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a research report on Thursday, August 21st. Finally, Robert W. Baird increased their price target on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,750,875. The trade was a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock valued at $2,371,208. 0.77% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of large investors have recently made changes to their positions in MTD. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the first quarter valued at $41,000. NewSquare Capital LLC raised its position in Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier's stock worth $41,000 after buying an additional 17 shares during the last quarter. MV Capital Management Inc. raised its position in Mettler-Toledo International by 50.0% during the 2nd quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier's stock worth $42,000 after buying an additional 12 shares during the last quarter. Zions Bancorporation National Association UT purchased a new position in Mettler-Toledo International during the 1st quarter worth approximately $43,000. Finally, Golden State Wealth Management LLC raised its position in Mettler-Toledo International by 583.3% during the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after buying an additional 35 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded down $7.80 during midday trading on Monday, hitting $1,257.79. 119,946 shares of the company's stock were exchanged, compared to its average volume of 121,738. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,521.01. The firm has a 50-day moving average of $1,264.75 and a two-hundred day moving average of $1,185.20. The company has a market cap of $25.91 billion, a PE ratio of 30.94, a P/E/G ratio of 3.79 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to analysts' expectations of $957.41 million. During the same period in the prior year, the business earned $9.65 EPS. The firm's quarterly revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.